Meta-analysis of the results of haploidentical transplantation in the treatment of aplastic anemia.

Abstract

This meta-analysis was to evaluate the outcome of haploidentical hematopoietic stem cell transplantation (Haplo-HSCT) for aplastic anemia (AA) compared with matched related donor (MRD)-HSCT, matched unrelated donor (MUD)-HSCT, and immunosuppressive therapy (IST). Pubmed, Embase, Cochrane Library, Web of Science, CNKI, WanFang, and VIP databases were searched for relevant studies from inception to 22 June 2022. Relative risk (RR) was used to indicate the effect indicator, with a 95% confidence interval (CI) being applied to express the effect size. A subgroup analysis based on the literature quality (low, fair, and high) was applied. Totally, 25 studies were included in this study, comprising 2252 patients. Our findings demonstrated no difference between Haplo-HSCT and MRD-HSCT in 1-, 2-, and 3-year overall survival (OS), failure-free survival (FFS), and engraftment. However, Haplo-HSCT had higher incidences of II-IV acute graft-versus-host disease (aGVHD), chronic GVHD (cGVHD), and cytomegalovirus infection. There were no differences in 3- and 5-year OS, 3-year FFS, platelet engraftment, graft failure (GF), II-IV grade of aGVHD, and complication between Haplo-HSCT and MUD-HSCT; however, Haplo-HSCT had a lower incidence of cGVHD. Compared with IST, Haplo-HSCT had a higher 3-year FFS and 3- and 6-month response rate. However, there were no differences in 3- and 5-year OS, and 12-month response rate between Haplo-HSCT and IST. This study suggests that Haplo-HSCT may be a realistic therapeutic option for AA, which may provide a reference for decision-making.

• Authors: Jin Zhao, Li Ma, Meijing Zheng, Liping Su, Xiaojing Guo
• Journal: Annals of hematology (Ann Hematol) Vol. 102 Issue 9 Pg. 2565-2587 (Sep 2023) ISSN: 1432-0584 [Electronic] Germany
• PMID: 37442821 (Publication Type: Meta-Analysis, Journal Article)
• Copyright: © 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Topics

• Humans
• Anemia, Aplastic
• Treatment Outcome
• Transplantation, Haploidentical (adverse effects)
• Retrospective Studies
• Graft vs Host Disease (etiology, prevention & control)
• Bronchiolitis Obliterans Syndrome
• Unrelated Donors
• Hematopoietic Stem Cell Transplantation (adverse effects)
• Transplantation Conditioning (methods)